https://orcid.org/0000-0002-3829-1697
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
ABSTRACT
The Queen Square Screening Test for Visual Deficits (QS test) screens for changes in visual processing. Our pilot study aimed to review the applicability of the QS test in individuals with dementia compared with those with normal cognition. Participants with major and minor neurocognitive disorder scored 50/71 (n=12) and 61/71 (n=10) respectively on the QS test, compared to 65/71 for age-matched healthy controls (n=11). The QS test score correlated with cognitive impairment as measured using the Rowland Universal Dementia Assessment Scale (r = 0.74). The QS test is an affordable and easy bedside screening test for visual processing changes.
Acknowledgments
Dr Rinaldo Gonzales, Dr David Conforti, and the Geriatrics and Neurology Departments at Liverpool Hospital for their assistance with patient recruitment and specialist opinion.
Declaration of interest statement
This study was conducted without any sponsorship or funding. The authors declare they have no financial relationships deemed relevant to the manuscript. None of the authors have any financial interest in the sale of the QS test.
Supplementary material
Supplemental data for this article can be accessed online at https://doi.org/10.1080/01658107.2021.1947324.